Roche envisions big sales for HDL, arthritis drugs - Reuters
February 9, 2007 Reuters | Roche envisions big sales for HDL, arthritis drugs Reuters - VX: Quote, Profile , Research) said on Friday the company's drug to raise "good" HDL cholesterol and its Actemra treatment for rheumatoid arthritis each ... |
Medal Program Showed Arthritis Patients Taking Arcoxia (etoricoxib ... - PharmaLive.com (press release)
February 9, 2007| Medal Program Showed Arthritis Patients Taking Arcoxia (etoricoxib ... PharmaLive.com (press release), PA - ... treatment with ARCOXIA (60 mg or 90 mg) daily or diclofenac (150 mg daily) in osteoarthritis (OA) and rheumatoid arthritis (RA) patient populations. ... MEDAL: Are the GI benefits of etoricoxib worthwhile? |
ImmuneRegen's Viprovex Demonstrates Immune Response Potential in ... - Yahoo! News (press release)
February 9, 2007| ImmuneRegen's Viprovex Demonstrates Immune Response Potential in ... Yahoo! News (press release) - Pre-clinical results of Viprovex, used in the treatment of cotton rats infected with the H3N2/Wuhan human influenza virus, provided indications that ... |
MEDAL Program Showed Arthritis Patients Taking ARCOXIA ... - dBusinessNews Newark (press release)
February 9, 2007| MEDAL Program Showed Arthritis Patients Taking ARCOXIA ... dBusinessNews Newark (press release), NJ - ... treatment with ARCOXIA (60 mg or 90 mg) daily or diclofenac (150 mg daily) in osteoarthritis (OA) and rheumatoid arthritis (RA) patient populations. ... MEDAL: Are the GI benefits of etoricoxib worthwhile? |
ImmuneRegen's Viprovex Demonstrates Immune Response Potential In ... - Medical News Today (press release)
February 9, 2007| ImmuneRegen's Viprovex Demonstrates Immune Response Potential In ... Medical News Today (press release), UK - Pre-clinical results of Viprovex, used in the treatment of cotton rats infected with the H3N2/Wuhan human influenza virus, provided indications that ... |